Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
US Stock MarketDetailed Quotes
NVCT Nuvectis Pharma
- 9.440
- -0.050-0.53%
Close Mar 18 16:00 ET
- 9.440
- 0.0000.00%
Post 20:01 ET
220.82MMarket Cap-8.50P/E (TTM)
9.500High8.810Low131.78KVolume9.500Open9.490Pre Close1.21MTurnover1.03%Turnover RatioLossP/E (Static)23.39MShares11.80052wk High22.75P/B120.53MFloat Cap4.44052wk Low--Dividend TTM12.77MShs Float20.920Historical High--Div YieldTTM7.27%Amplitude3.080Historical Low9.169Avg Price1Lot Size
About Nuvectis Pharma Company
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Company Profile
SymbolNVCT
Company NameNuvectis Pharma
Listing DateFeb 4, 2022
Issue Price5.00
Founded2020
CEOMr. Ron Bentsur
MarketNASDAQ
Employees13
Fiscal Year Ends12-31
Address1 Bridge Plaza,Suite 275,2nd floor
CityFort Lee
ProvinceNew Jersey
CountryUnited States of America
Zip Code07024
Phone1-201-614-3151
Websitehttp://nuvectis.com
Company Executives
- Name
- Position
- Salary
- Ron Bentsur
- Chairman of the Board, Chief Executive Officer and President
- 2.69M
- Shay Shemesh
- Executive Vice President, Chief Development and Operations Officer
- 1.56M
- Enrique Poradosu
- Executive Vice President, Chief Scientific and Business Officer
- 1.56M
- Michael J. Carson
- Vice President of Finance, Principal Financial and Accounting Officer
- --
- James F. Oliviero, III
- Independent Director
- 385.80K
- Matthew L. Kaplan
- Independent Director
- 375.80K
- Kenneth Hoberman
- Independent Director
- 385.80K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.